Definium Therapeutics Inc. Common Shares vs HF Sinclair Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.09 (market cap $4.59B), while HF Sinclair Corporation Common Stock trades at $120.35 (market cap $21.46B). The key difference: HF Sinclair Corporation Common Stock is far larger — about 4.7× Definium Therapeutics Inc. Common Shares's market cap, and HF Sinclair Corporation Common Stock pays a 1.74% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and HF Sinclair Corporation Common Stock for 0 Days on average.
| DFTX | DINO | |
|---|---|---|
Market Cap | $4.59B | $21.46B |
Volume | 2,103,937 | 2,430,580 |
Sector | Health | Energy |
52-Week High | $48.45 | $120.72 |
52-Week Low | $10.68 | $45.88 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $22.44B |
Dividend Yield | — | 1.74% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →HF Sinclair refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics and renewable fuels businesses.
Read more on DINO →